SIRT1 and Parkinson disease: In models of PD, rotenone and MPP+ are known to reduce SIRT1 in primary cultures which may imply that due to reduction of SIRT1, neurones have reduced ability to combat oxidative stress and mitochondrial dysfunction [11].